Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1573 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lipoxen Updates On Baxter Partnership

The exclusive world-wide development and licence agreement is based on the PolyXen PSA-Factor VIII project being developed with Baxter, a treatment of haemophilia, for improved longer-acting forms of

Intellipharmaceutics Submits Protonix ANDA

Protonix inhibits gastric acid secretion and is prescribed for the short-term treatment of conditions such as stomach ulcers associated with gastroesophageal reflux disease as well as the long